Torrent Pharmaceuticals Ltd (TORNTPHARM):製薬・医療:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C10133)
◆英語タイトル:Torrent Pharmaceuticals Ltd (TORNTPHARM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10133
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年11月
◆ページ数:47
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥36,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥73,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥109,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Torrent Pharmaceuticals Ltd (Torrent) manufactures and markets branded and unbranded generic pharmaceuticals. It provides products in cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective and pain management segments. Also, the company has presence in nephrology, cancer, gynecology and pediatric segments. Torrent has a fully equipped research center that is approved by the US FDA and various other regulatory authorities and manufacturing facilities at Indrad, Baddi, Sikkim, Dahej and Pithampur. The company has presence in more than forty countries worldwide and has wholly owned subsidiaries in USA, the UK, Germany, Russia, Brazil, Mexico, Philippines and other major markets. Torrent is headquartered in Ahmedabad, Gujarat, India.

Torrent Pharmaceuticals Ltd (TORNTPHARM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Torrent Pharma Acquires Branded Business from Unichem Labs for USD556.6 Million 13
Torrent Pharma Acquires Two Brands of Women Healthcare Segment from Novartis 15
Torrent Pharma Acquires Active Pharmaceutical Ingredients Manufacturing Unit in Vizag from Glochem Industries 16
Torrent Pharma to Acquire Minocycline Tablet From Ranbaxy Labs 17
Torrent Pharma Completes Acquisition Of Formulations Business Of Elder Pharma For US$333 Million 18
Private Equity 20
ChrysCapital Acquires 3% Stake In Torrent Pharma For US$40 Million 20
Partnerships 21
Navamedic Enters Into Distribution Agreement With Torrent Pharma 21
Licensing Agreements 22
Torrent Pharma Enters into Licensing Agreement with Reliance Life Sciences 22
Equity Offering 23
Torrent Pharma May Raise USD231 Million in Private Placement of Share 23
Torrent Pharma Plans to Raise up to USD782 Million in Private Placement of Securities 24
Vista Pharma to Raise Funds through Public Offering of Shares and Warrants 25
Torrent Pharma Plans Private Placement of Shares for USD488.2 Million 26
Debt Offering 27
Torrent Pharma Plans to Raise up to USD1.95 Billion in Private Placement of Debt Securities 27
Torrent Pharma Raises USD155 Million in Private Placement of 7.98% Debentures Due 2025 28
Torrent Pharma Plans Private Placement of Bonds for USD1.22 Billion 29
Acquisition 30
Torrent Pharma Acquires Bio-Pharm 30
ChrysCapital Divests Stake in Torrent Pharma 31
Torrent Pharma Acquires Zyg Pharma 32
Torrent Pharma Plans To Acquire Pharma Companies 33
Torrent Pharmaceuticals Ltd – Key Competitors 34
Torrent Pharmaceuticals Ltd – Key Employees 35
Torrent Pharmaceuticals Ltd – Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Recent Developments 39
Financial Announcements 39
Nov 03, 2018: Torrent Pharma Q2 net drags 12% to Rs 1.7 bn on rupee decline, US recall 39
Jul 31, 2017: Torrent Pharma announces Q1 FY 2017-18 Results 40
May 26, 2017: Torrent Pharmaceuticals Reports Revenue Of INR19.8 Billion In Fiscal 2017 42
Corporate Communications 43
Aug 31, 2018: Torrent Pharmaceuticals: Intimation of change in Chief Financial Officer 43
Jul 26, 2018: Torrent Pharmaceuticals: Intimation of cessation of director of the company 44
Jul 22, 2017: Torrent Pharmaceuticals : Intimation of Resignation of Director of the Company 45
Product News 46
Aug 23, 2018: Torrent Pharmaceuticals limited issues voluntary nationwide recall of Valsartan/Amlodipine/HCTZ, Valsartan/Amlodipine and Valsartan Tablets 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47

List of Tables
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Torrent Pharmaceuticals Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Torrent Pharma Acquires Branded Business from Unichem Labs for USD556.6 Million 13
Torrent Pharma Acquires Two Brands of Women Healthcare Segment from Novartis 15
Torrent Pharma Acquires Active Pharmaceutical Ingredients Manufacturing Unit in Vizag from Glochem Industries 16
Torrent Pharma to Acquire Minocycline Tablet From Ranbaxy Labs 17
Torrent Pharma Completes Acquisition Of Formulations Business Of Elder Pharma For US$333 Million 18
ChrysCapital Acquires 3% Stake In Torrent Pharma For US$40 Million 20
Navamedic Enters Into Distribution Agreement With Torrent Pharma 21
Torrent Pharma Enters into Licensing Agreement with Reliance Life Sciences 22
Torrent Pharma May Raise USD231 Million in Private Placement of Share 23
Torrent Pharma Plans to Raise up to USD782 Million in Private Placement of Securities 24
Vista Pharma to Raise Funds through Public Offering of Shares and Warrants 25
Torrent Pharma Plans Private Placement of Shares for USD488.2 Million 26
Torrent Pharma Plans to Raise up to USD1.95 Billion in Private Placement of Debt Securities 27
Torrent Pharma Raises USD155 Million in Private Placement of 7.98% Debentures Due 2025 28
Torrent Pharma Plans Private Placement of Bonds for USD1.22 Billion 29
Torrent Pharma Acquires Bio-Pharm 30
ChrysCapital Divests Stake in Torrent Pharma 31
Torrent Pharma Acquires Zyg Pharma 32
Torrent Pharma Plans To Acquire Pharma Companies 33
Torrent Pharmaceuticals Ltd, Key Competitors 34
Torrent Pharmaceuticals Ltd, Key Employees 35
Torrent Pharmaceuticals Ltd, Other Locations 36
Torrent Pharmaceuticals Ltd, Subsidiaries 36

List of Figures
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Torrent Pharmaceuticals Ltd (TORNTPHARM):製薬・医療:M&Aディール及び事業提携情報(Torrent Pharmaceuticals Ltd (TORNTPHARM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆